Skip to content
NVCR NovoCure Limited Ordinary Shares
$12.42 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy NVCR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.4B
Enterprise value 1.2B
Trailing PE -10.229507821505
Forward PE -10.697344
PEG Ratio 0.15999999413123
Enterprise to EBITDA -9.024
Enterprise to revenue 1.861
Price to book MRQ 4.1195903
Price to sales TTM 2.203831

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 655.4M
EBITDA -135159008
Diluted EPS TTM -1.22
Total Cash (MRQ) 447.7M
Current ratio (MRQ) 2.897
Operating Cash Flow (TTM) -49031000

NVCR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent NVCR News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.